Isolation Facilities for Highly Infectious Diseases in Europe – A Cross-Sectional Analysis in 16 Countries
Authors:
- Stefan SchillingSSStefan Schilling
- Francesco Maria FuscoFFFrancesco Maria Fusco
- Giuseppina De IacoGIGiuseppina De Iaco
- Barbara BannisterBBBarbara Bannister
- Helena C. MaltezouHelena C. Maltezou
- Gail CarsonGCGail Carson
- Rene GottschalkRGRene Gottschalk
- Vincenzo PuroVPVincenzo Puro
- Giuseppe IppolitoGIGiuseppe Ippolito
- For The European Network For Highly Infectious Diseases Project MembersFMFor The European Network For Highly Infectious Diseases Project Members
Open Access
- 28 October 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (10) , e100401
Abstract
Highly Infectious Diseases (HIDs) are (i) easily transmissible form person to person; (ii) cause a life-threatening illness with no or few treatment options; and (iii) pose a threat for both personnel and the public. Hence, even suspected HID cases should be managed in specialised facilities minimizing infection risks but allowing state-of-the-art critical care. Consensus statements on the operational management of isolation facilities have been published recently. The study presented was set up to compare the operational management, resources, and technical equipment among European isolation facilities. Due to differences in geography, population density, and national response plans it was hypothesized that adherence to recommendations will vary. Until mid of 2010 the European Network for Highly Infectious Diseases conducted a cross-sectional analysis of isolation facilities in Europe, recruiting 48 isolation facilities in 16 countries. Three checklists were disseminated, assessing 44 items and 148 specific questions. The median feedback rate for specific questions was 97.9% (n = 47/48) (range: n = 7/48 (14.6%) to n = 48/48 (100%). Although all facilities enrolled were nominated specialised facilities' serving countries or regions, their design, equipment and personnel management varied. Eighteen facilities fulfilled the definition of a High Level Isolation Unit'. In contrast, 24 facilities could not operate independently from their co-located hospital, and five could not ensure access to equipment essential for infection control. Data presented are not representative for the EU in general, as only 16/27 (59.3%) of all Member States agreed to participate. Another limitation of this study is the time elapsed between data collection and publication; e.g. in Germany one additional facility opened in the meantime. There are disparities both within and between European countries regarding the design and equipment of isolation facilities. With regard to the International Health Regulations, terminology, capacities and equipment should be standardised.Keywords
This publication has 24 references indexed in Scilit:
- Personal Protective Equipment Management and Policies: European Network for Highly Infectious Diseases Data from 48 Isolation Facilities in 16 European CountriesInfection Control & Hospital Epidemiology, 2012
- Diagnostic issues and capabilities in 48 isolation facilities in 16 European countries: data from EuroNHID surveysBMC Research Notes, 2012
- Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control studyBMJ, 2012
- Infection control practices in facilities for highly infectious diseases across EuropeJournal of Hospital Infection, 2012
- Infection control management of patients with suspected highly infectious diseases in emergency departments: data from a survey in 41 facilities in 14 European countriesBMC Infectious Diseases, 2012
- Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, GermanyThe Journal of Infectious Diseases, 2011
- Isolation rooms for highly infectious diseases: an inventory of capabilities in European countriesJournal of Hospital Infection, 2009
- EuroNHID checklists for the assessment of high-level isolation units and referral centres for highly infectious diseases: results from the pilot phase of a European surveyClinical Microbiology and Infection, 2009
- The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threatsClinical Microbiology and Infection, 2009
- Designing a Biocontainment Unit to Care for Patients with Serious Communicable Diseases: A Consensus StatementBiosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 2006